---
title: 'The high-grade B-cell lymphomas: Double hit and more'
date: '2024-10-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39427343/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241021184313&v=2.18.0.post9+e462414
source: Blood
description: Both the 2022 WHO HAEM5 and the International Consensus Classification
  of lymphoma have refined the way we now approach high-grade B-cell lymphoma (HGBL)
  with MYC and BCL2 and/or BCL6 rearrangements moving the previous generation of classification
  a step forward. The unifying biology of MYC/BCL2 tumours has been clearer and their
  inferior prognosis confirmed compared to those with morphological similarities but
  lacking the classifying cytogenetic abnormalities. FISH testing has largely ...
disable_comments: true
---
Both the 2022 WHO HAEM5 and the International Consensus Classification of lymphoma have refined the way we now approach high-grade B-cell lymphoma (HGBL) with MYC and BCL2 and/or BCL6 rearrangements moving the previous generation of classification a step forward. The unifying biology of MYC/BCL2 tumours has been clearer and their inferior prognosis confirmed compared to those with morphological similarities but lacking the classifying cytogenetic abnormalities. FISH testing has largely ...